We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
-12.77%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$44.2B
AUM Growth
-$8.44B
(-16%)
Cap. Flow
-$301M
Cap. Flow
% of AUM
-0.68%
Top 10 Holdings %
Top 10 Hldgs %
14.01%
Holding
2,360
New
150
Increased
1,005
Reduced
998
Closed
187
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$209M |
| 2 |
CVS Health
CVS
|
+$195M |
| 3 |
Tyson Foods
TSN
|
+$136M |
| 4 |
ExxonMobil
XOM
|
+$135M |
| 5 |
LyondellBasell Industries
LYB
|
+$130M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$239M |
| 2 |
Microsoft
MSFT
|
+$204M |
| 3 |
Johnson & Johnson
JNJ
|
+$157M |
| 4 |
Amazon
AMZN
|
+$144M |
| 5 |
Walmart Inc
WMT
|
+$137M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.23% |
| 2 | Healthcare | 16.49% |
| 3 | Financials | 11.74% |
| 4 | Industrials | 11.47% |
| 5 | Consumer Discretionary | 10.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1101
Century Communities
CCS
$1.98B
| $1.97M | ﹤0.01% |
43,808
+1,200
| +3% | +$60.6K |
|
1102
Standex International
SXI
$4B
| $1.97M | ﹤0.01% |
23,215
-1,512
| -6% | -$142K |
|
1103
TTM Technologies
TTMI
$14.6B
| $1.97M | ﹤0.01% |
157,288
+1,325
| +0.8% | +$18.3K |
|
1104
Hope Bancorp
HOPE
$1.82B
| $1.97M | ﹤0.01% |
141,989
+115,608
| +438% | +$1.69M |
|
1105
Univest Financial
UVSP
$1.18B
| $1.96M | ﹤0.01% |
76,999
+10,583
| +16% | +$271K |
|
|
DRD
1106
DRDGold
DRD
$2.09B
| $1.96M | ﹤0.01% |
333,359
-157,231
| -32% | -$1.17M |
|
1107
1st Source
SRCE
$2.13B
| $1.95M | ﹤0.01% |
42,999
-458
| -1% | -$20.7K |
|
1108
Celsius Holdings
CELH
$6.86B
| $1.95M | ﹤0.01% |
89,706
+58,452
| +187% | +$1.13M |
|
1109
Selective Insurance
SIGI
$5.61B
| $1.95M | ﹤0.01% |
23,004
+5,159
| +29% | +$420K |
|
1110
Evolent Health
EVH
$465M
| $1.94M | ﹤0.01% |
63,200
+12,734
| +25% | +$371K |
|
1111
Rimini Street
RMNI
$442M
| $1.94M | ﹤0.01% |
322,480
+40,922
| +15% | +$244K |
|
1112
Centrus Energy
LEU
$3.74B
| $1.93M | ﹤0.01% |
78,151
+49,605
| +174% | +$1.37M |
|
1113
RPC Inc
RES
$1.39B
| $1.93M | ﹤0.01% |
278,931
+190,600
| +216% | +$1.82M |
|
|
NXGN
1114
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $1.92M | ﹤0.01% |
110,182
-22,099
| -17% | -$421K |
|
1115
Amerant Bancorp
AMTB
$1.14B
| $1.92M | ﹤0.01% |
68,186
+38,737
| +132% | +$1.1M |
|
1116
Match Group
MTCH
$8.38B
| $1.92M | ﹤0.01% |
28,098
-27,337
| -49% | -$2.22M |
|
1117
OceanFirst Financial
OCFC
$1.85B
| $1.92M | ﹤0.01% |
100,091
+25,316
| +34% | +$485K |
|
1118
Sinclair Inc
SBGI
$991M
| $1.91M | ﹤0.01% |
+96,148
| New | +$2.23M |
|
1119
Nektar Therapeutics
NKTR
$2.56B
| $1.9M | ﹤0.01% |
33,306
+21,162
| +174% | +$1.34M |
|
1120
Byline Bancorp
BY
$1.77B
| $1.89M | ﹤0.01% |
79,295
-2,647
| -3% | -$64K |
|
1121
PennyMac Financial
PFSI
$3.95B
| $1.88M | ﹤0.01% |
43,093
-7,497
| -15% | -$354K |
|
1122
Genco Shipping & Trading
GNK
$1.09B
| $1.88M | ﹤0.01% |
97,346
-1,330
| -1% | -$30K |
|
|
FFWM
1123
DELISTED
First Foundation Inc
FFWM
| $1.88M | ﹤0.01% |
91,722
+23,063
| +34% | +$510K |
|
1124
M/I Homes
MHO
$3.8B
| $1.87M | ﹤0.01% |
47,064
-10,680
| -18% | -$464K |
|
1125
Conduent
CNDT
$240M
| $1.86M | ﹤0.01% |
431,816
+62,160
| +17% | +$312K |
|
Similar funds
VGA
AQR Capital Management's Q2 2022 Portfolio in Review
As of Q2 2022, AQR Capital Management held 2,360 positions worth $44.2B, down 16% from $52.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
AQR Capital Management's Q2 2022 filing shows 150 new, 1,005 increased, 998 reduced and 187 closed positions. Its largest new stake was Fluor: 339,891 shares worth $7.86M. The largest sale was Thermo Fisher Scientific, an estimated $239M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
- AQR Capital Management's largest Q2 2022 buy was Fluor: 339,891 shares worth $7.86M.
- AQR Capital Management added most to Gilead Sciences in Q2 2022, an estimated $209M increase.
- AQR Capital Management's biggest Q2 2022 reduction was Thermo Fisher Scientific, cutting an estimated $239M.
- AQR Capital Management fully exited Roku in Q2 2022, selling an estimated $32.5M.
- AQR Capital Management's ten largest holdings make up 14% of its $44.2B portfolio in Q2 2022.
- AQR Capital Management opened 150 new positions and closed 187 in Q2 2022.
- AQR Capital Management's portfolio value fell 16% quarter-over-quarter to $44.2B.
Based on AQR Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.